Tygh Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
Tygh Capital Management's CDNA Position: Q4 2021 in Review
Tygh Capital Management reduced its CareDx (CDNA) stake by 16% in Q4 2021, selling an estimated $255K and leaving 25,831 shares worth $1.18M. The position accounts for 0.15% of the portfolio, ranked #82.
Tygh Capital Management first reported a position in CDNA in Q3 2021 and has held it in 2 quarters since. The position peaked at $1.95M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.
- Tygh Capital Management held 25,831 shares of CareDx worth $1.18M as of Q4 2021.
- Tygh Capital Management sold 4,889 CareDx shares in Q4 2021, an estimated $255K.
- CareDx made up 0.15% of Tygh Capital Management's portfolio in Q4 2021, its #82 holding.
- Tygh Capital Management first reported a position in CareDx in Q3 2021 and has held it in 2 quarters since.
- Tygh Capital Management's CareDx position peaked at $1.95M in Q3 2021.
- 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.
Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.